All Posts Tagged:
April 23, 2019
Continuing from last week's post, the next step would be the regulatory submission process, which can fluctuate based upon the commercial and...
April 16, 2019
The Pharmaceutical development timeline is littered with regulatory considerations, one of which is the review of a Proprietary (Invented or...
February 20, 2017
POCA, defined by the Federal Drug Administration (FDA) as the Phonetic and Orthographic Computer Analysis program, “is an analytic tool designed...